Remove Containment Remove Reagent Remove Sales
article thumbnail

Leading API biologics (protein and peptide) companies in contract marketing

Pharmaceutical Technology

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision. Technologies in the delivery of peptides and proteins. The advancement in drug design has led to the development of new drug molecules in the form of API peptides and proteins.

Protein 100
article thumbnail

Avacta Announces Collaboration Agreement With Bruker

The Pharma Data

Avacta has worked with Adeptrix Inc (Beverly, MA, USA) to develop a coronavirus antigen test that combines enrichment of the sample using Affimer® reagents with the analytical power of mass-spectrometry. 28, 2021 09:19 UTC. CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.–( View source version on businesswire.com: [link].

Reagent 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog

The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software. The PR states that LDTs are not the “practice of medicine,” with which FDA generally may not interfere.

article thumbnail

New Sandoz Board of Directors appointed

The Pharma Data

She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Aarti Shah, PhD former Chief Information and Digital Officer & Senior Vice President at Eli Lilly and Company between 2016 and 2021, a US-headquartered pharmaceutical company with approximately US$ 28 billion in sales in 2021.

Sales 40
article thumbnail

Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing

The Pharma Data

Laboratory Implementation Laboratory reagents for performing the test commercially have been designed and are currently being validated in preparation for regulatory submission to CMS/CLIA with a view to targeting sales in the USA initially. This is also expected to provide greater flexibility for potential distribution partners.